Feature | Thrombosis and COVID-19: FAQs For Current Practice

Geoffrey D. Barnes
Adam Cuker
Tyler J Gluckman, Providence Heart and Vascular Institute, Portland, OR, USA.
Gregory Piazza
Deborah M. Siegal


An FAQ on the potential impact of COVID-19 on thrombotic and/or bleeding risk from ACC's Science and Quality Committee summarize the current data on the risk, potential need for hemostasis/coagulation testing, VTE prophylaxis, and therapeutic anticoagulation in patients with COVID-19 without confirmed/suspected thrombosis.